Decanoyl-RVKR-CMK structure
|
Common Name | Decanoyl-RVKR-CMK | ||
---|---|---|---|---|
CAS Number | 150113-99-8 | Molecular Weight | 744.41 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C34H66ClN11O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Decanoyl-RVKR-CMKDecanoyl-RVKR-CMK (DecRVKRcmk) inhibits over-expressed gp160 processing and HIV-1 replication[1]. |
Name | Furin Convertase Inhibitor ( Chloromethylketone) |
---|---|
Synonym | More Synonyms |
Description | Decanoyl-RVKR-CMK (DecRVKRcmk) inhibits over-expressed gp160 processing and HIV-1 replication[1]. |
---|---|
Related Catalog | |
In Vitro | Decanoyl-RVKR-CMK (DecRVKRcmk) inhibits HIV-2ROD replication by blocking envelope glycoprotein precursor processing in the Jurkat lymphocyte cell[1].Decanoyl-RVKR-CMK (DecRVKRcmk) blocks regulated secretion of VGF[2]. Cell Viability Assay Cell Line: HeLaCD4 cells infected with recombinant vaccinia viruses at a multiplicity of infection (MOI) of 5 PFU/mL[1]. Concentration: 35 and 70 µΜ. Incubation Time: 7 days. Result: Peptide at 35 µM significantly inhibited ex vivo HIV-1 and HIV-2 replications (70–80% inhibition). |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Molecular Formula | C34H66ClN11O5 |
Molecular Weight | 744.41 |
Exact Mass | 743.493713 |
PSA | 283.29000 |
LogP | 3.38 |
Index of Refraction | 1.585 |
decanoyl RVKR-CMK |
N-Decanoyl-N-(diaminomethylene)-L-ornithyl-L-valyl-N-{(3S)-1-chloro-6-[(diaminomethylene)amino]-2-oxo-3-hexanyl}-L-lysinamide |
decanoyl-Arg-Val-Lys-Arg-chloromethylketone |
Decanoic acid,4-formyl-2-methoxyphenyl ester |
L-Lysinamide, N-(diaminomethylene)-N-(1-oxodecyl)-L-ornithyl-L-valyl-N-[(1S)-1-(2-chloroacetyl)-4-[(diaminomethylene)amino]butyl]- |
4-formyl-2-methoxyphenyl decanoate |
decanoyl vanillin |
decanoyl-RVKR-chloromethylketone |
Dec-RVKR-CMK |